AiCure

Drug Sponsors

Bristol-Myers Squibb to build state-of-the-art campus in New Jersey

Thursday, September 25, 2014 12:52 PM

Bristol-Myers Squibb plans to build a 650,000-square-foot office building on company-owned land in Lawrenceville, N.J. Construction is expected to begin in the fall and the new facility is expected to open by the end of 2016.

More... »


Acorda Therapeutics to acquire Civitas Therapeutics

Thursday, September 25, 2014 12:48 PM

Acorda Therapeutics, a biotechnology company based in Ardsley, N.Y., has entered into an agreement to acquire Civitas Therapeutics, a Chelsea, Mass.-based, privately held biopharmaceutical company, for $525 million in cash. Acorda will obtain worldwide rights to CVT-301, a phase III treatment candidate for OFF episodes of Parkinson’s disease (PD). The acquisition also includes rights to Civitas’ proprietary ARCUS pulmonary delivery technology and manufacturing facility with commercial-scale capabilities.

More... »

CenterWatch

Shire to pay $56.5M to U.S. government

Thursday, September 25, 2014 12:43 PM

Shire has reached a final agreement with the U.S. Attorney’s Office to resolve a civil investigation of its sales and marketing practices for a period ending in 2010 relating to Adderall XR, Vyvanse, Daytrana, Lialda and Pentasa. Shire will pay $56.5 million, plus interest, fees and costs.

More... »

Cytori restructures, cuts third of work force

Wednesday, September 24, 2014 01:27 PM

Cytori Therapeutics, a San Diego-based developer of cell therapies based on autologous adipose-derived regenerative cells (ADRCs), plans to restructure its operations and reduce costs.

More... »

Avalon Ventures, GlaxoSmithKline launch two new companies

Tuesday, September 23, 2014 09:00 AM

Avalon Ventures has announced the launch of two new companies, Silarus Therapeutics and Thyritope Biosciences, formed through its collaboration with GlaxoSmithKline (GSK) to fund and launch up to 10 early-stage life science companies. Both companies will be located at COI Pharmaceuticals in San Diego, a community established by Avalon Ventures to provide operational support, a fully equipped R&D facility and an experienced leadership team to its life science portfolio companies.

More... »

Study: Finding contributions and needs of life sciences industry in New Jersey

Monday, September 22, 2014 02:32 PM

Recognizing the continuing evolution of New Jersey’s life sciences industry, BioNJ has released a comprehensive report that documents the ongoing growth of the biotechnology sector in the state and combines and assesses the contributions of the entirety of the life sciences sector to New Jersey’s economy, including employment and economic impact.

More... »

Merck to acquire Sigma-Aldrich

Monday, September 22, 2014 02:31 PM

Merck has agreed to acquire Sigma-Aldrich, a St. Louis, Mo.-based life science and technology company, for $17 billion in an all-cash transaction.

More... »

Cubist opens international headquarters in Zurich

Monday, September 22, 2014 02:25 PM

Cubist Pharmaceuticals, a company focused on novel antibiotics, has announced the official opening of its international headquarters in Zurich, Switzerland. Located in a growing biopharmaceutical hub in Switzerland, the company's international operations complement its corporate headquarters in Lexington, Mass.

More... »

Nanobiotix expands into the U.S.

Monday, September 22, 2014 02:24 PM

Nanobiotix, a Paris-headquartered clinical-stage nanomedicine company, has opened its first U.S. office in Boston.

More... »

GlaxoSmithKline to pay $485.2M fine to Chinese government in bribery scandal

Friday, September 19, 2014 01:31 PM

GlaxoSmithKline has confirmed the Changsha Intermediate People’s Court in Hunan Province, China ruled GSK China Investment (GSKCI) has, according to Chinese law, offered money or property to non-government personnel in order to obtain improper commercial gains, and has been found guilty of bribing non-government personnel. The verdict follows investigations initiated by China’s Ministry of Public Security in June 2013. 

More... »

Link to survey
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

November 17

PPD, Medidata join their technologies for risk-based monitoring, adaptive trial design

ERT acquires eClinical Insights in "strategic combination" to gain cloud-based trial software platform, expertise

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

October

CROs driving changes in patient recruitment
Data- and tech-aided enrollment services a competitive advantage

Trials with in-home nurses poised to grow
Higher expense, but may improve recruitment and retention for select trials

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs